CARDIOPRIME Trademark

Trademark Overview

On Tuesday, January 16, 2018, a trademark application was filed for CARDIOPRIME with the United States Patent and Trademark Office. The USPTO has given the CARDIOPRIME trademark a serial number of 87757419. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, July 7, 2025. This trademark is owned by AnaBios Corporation. The CARDIOPRIME trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Testing of pharmaceuticals
cardioprime

General Information

Serial Number87757419
Word MarkCARDIOPRIME
Filing DateTuesday, January 16, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, July 7, 2025
Registration Number5698894
Registration DateTuesday, March 12, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 29, 2018

Trademark Statements

Pseudo MarkCARDIO PRIME
Goods and ServicesTesting of pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 29, 2018
Primary Code042
First Use Anywhere DateFriday, May 25, 2018
First Use In Commerce DateFriday, May 25, 2018

Trademark Owner History

Party NameAnaBios Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92101
Party NameAnaBios Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92109
Party NameAnaBios Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92109

Trademark Events

Event DateEvent Description
Wednesday, April 25, 2018ASSIGNED TO EXAMINER
Friday, January 19, 2018NEW APPLICATION ENTERED
Monday, January 29, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 25, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 9, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 29, 2018PUBLISHED FOR OPPOSITION
Tuesday, May 29, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 24, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 19, 2018TEAS STATEMENT OF USE RECEIVED
Wednesday, December 19, 2018USE AMENDMENT FILED
Wednesday, January 23, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 23, 2019STATEMENT OF USE PROCESSING COMPLETE
Wednesday, February 6, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, February 7, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 12, 2019REGISTERED-PRINCIPAL REGISTER
Monday, April 10, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 10, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 10, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, April 10, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 10, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 10, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 10, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, April 10, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, March 9, 2025TEAS SECTION 8 & 15 RECEIVED
Monday, July 7, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, July 7, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, July 7, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, March 12, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

cardioprime pharmaceuticals testing